Michael Geffner
Direttore Tecnico/Scientifico/R&S presso IMMUNOVANT, INC.
Patrimonio netto: 4 M $ in data 31/05/2024
Profilo
Michael Geffner is currently the Chief Medical Officer at Immunovant, Inc. He previously worked as the Senior VP-Development & Medical Affairs at Achillion Pharmaceuticals, Inc. He holds an MBA from Fairleigh Dickinson University and a doctorate from Albany Medical College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOVANT INC
0.10% | 24/04/2024 | 141 616 ( 0.10% ) | 4 M $ | 31/05/2024 |
Posizioni attive di Michael Geffner
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOVANT, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Michael Geffner
| Società | Posizione | Fine |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/01/2020 |
Formazione di Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Borsa valori
- Insiders
- Michael Geffner
